(J Clin Gastroenterol 2009;43:580-585) E laborating reliable tools to predict outcome in patients with chronic liver disease remains a challenge for physicians specialized in hepatology. The main goal is to establish a single score resulting from the sum of a subset of individual variables, each being supposed to weigh on the progression of the disease. Most scores, including the Child-Pugh (CP) score, rely on a limited number of variables, which, in light of clinical experience, were felt to affect prognosis and were put together empirically. In contrast, more recent scores, including the model for endstage liver disease (MELD), are based on a subset of variables, which were found by multivariate analysis to be independent predictors of mortality.
The MELD was originally created for the prediction of mortality after transjugular intrahepatic portosystemic shunt. 1 On the basis of simple, readily available, and reproductive variables [serum creatinine, bilirubin, international normalized ratio (INR), and initially etiology], the MELD allows the identification of patients with end-stage liver disease and a median survival as short as 3 months. 2 Because of the objective nature of its components and its ability to identify increasing death risk, this score was adopted by the United Network for Organ Sharing (UNOS) in place of the CP score for the allocation of livers from deceased donors. 3 However, the MELD shares several limitations such as empirical selection of variables included in multivariate analysis, alteration of serum creatinine and bilirubin by therapeutic intervention, sepsis, or hemolysis. 4 There is no real discriminant clear-cut value, and MELD calculation requires a computer, whereas the familiar CP score is currently and easily calculated at bedside. If the MELD represents determinant progress in terms of methodology and validation, its accuracy for the prediction of outcome in cirrhotic patients is also not always superior-and may even be inferior-to the one of CP score. [4] [5] [6] Studies have already shown that the addition of variables like serum sodium (Na) or ascites may improve the predictive accuracy of the MELD. 7, 8 In this setting, a new score combining MELD and serum Na was proposed: the MELD-Na. 9 Similarly, a recent study concluded that the prognostic accuracy of the CP score is significantly improved by the addition of hyaluronan, especially in alcoholic etiology. 10 The main aim of the present prospective study was to compare the accuracy of the MELD, the MELD-Na, and the CP score for the prediction of 6-month mortality in a population of cirrhotic patients from a French general hospital. The secondary aim was to determinate which variables could improve the performance of the MELD and the CP score for the prediction of 6-month mortality.
PATIENTS AND METHODS

Patients, Data Collection, and Follow-up Patients
All consecutive cirrhotic inpatients or outpatients admitted from November 2003 to December 2004 in the Hepato-Gastroenterology Unit of Le Mans Hospital (France) were prospectively included in this study. Diagnosis of liver cirrhosis was histologic, or based on agreed clinical, biologic, endoscopic, and radiologic data. Exclusion criteria were spontaneous bacterial peritonitis, hepatorenal syndrome, hepatocellular carcinoma, and other extrahepatic affections with poor short-term survival (endstage lung or other extrahepatic cancer, severe cardiomyopathy, etc). All patients gave their informed consent before being included. The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the local Ethics Committee.
Data Collection
Data were recorded at admission. Clinical data recorded were age, sex, cause of cirrhosis, ascites, encephalopathy, and variceal bleeding. Analyses of blood samples provided the following variables: alanine aminotransferase, aspartate aminotransferase, g-glutamyltransferase, alkaline phosphatase, total bilirubin, prothrombin index, INR, albumin, hyaluronic acid, platelet count, hematocrit, Na, urea, and creatinine. Esophageal varice was the only endoscopic parameter recorded. All patients were followed after discharge from hospital for at least 6 months. For patients lost to follow-up before 6 months, data were censored at the last follow-up.
Calculation of the MELD and the CP Score MELD
The MELD was calculated as follows: MELD = 9.57 Â LN creatinine+3.78 Â LN bilirubin+11.2 Â LN INR+6.43, with serum creatinine and bilirubin expressed in mg/dL. According to the latest UNOS modifications, laboratory values below 1.0 were rounded up to 1.0 to avoid negative scores, and the maximum serum creatinine considered within the MELD equation was 4.0 mg/dL.
MELD-Na
The MELD-Na score was calculated according to Biggins et al. 9 First, the MELD was calculated as previously, but without upper or lower limits in input variables. The MELD-Na was then calculated using the following formula: MELD-Na = MELD+1.59 Â (135-Na), where the minimum value for serum Na was 120 mEq/L and the maximum 135 mEq/L. Thus, because it was calculated without upper or lower limits for INR, creatinine, and bilirubin, the MELD-Na according to Biggins et al may be lower than the MELD provided by the UNOS.
CP Score
The CP score was calculated according to the method summarized in Table 1 . The CP score ranged from 5 to 15 and allowed the categorization of patients in 3 groups: patients with 5 to 6 points were classified as CP class A, 7 to 9 points as CP class B, and Z10 points as CP class C.
Statistical Methods
The main end point of the study was 6-month mortality. At first, we evaluated the accuracy of CP, MELD, and MELD-Na scores. The accuracy of each score was mainly expressed either by the area under the receiver operating characteristic curve (AUROC), or by the overall accuracy, that is true positives and negatives. Best cut-off value of each score was calculated according to the highest Youden index (sensitivity+ specificity À 1). AUROC were compared using the Delong test 11 and overall accuracies using the McNemar test.
Subsequently, we tried to improve the CP score accuracy. In this setting, we first performed a univariate analysis using w 2 or t test to identify the baseline variables that differed significantly between living and deceased patients at 6 months. Second, the CP score and all variables with a univariate Pr0.05 (except the variables already included in the CP score) were included in a stepwise binary logistic regression using 6-month mortality as dependent binary variable. The logistic regression method was used because our objective was to predict, in a binary fashion, whether a patient would be alive after 6 months regardless of the time of death. The logistic regression provided an R function including the independent predictors. A score ranging from 0 to 1 was then constructed using the following formula: 1/[1+exp ( À R)]. Difference of accuracy between this ''optimized CP'' and the original CP score was assessed by comparing their AUROC. The same method was used with the MELD.
Statistical analysis was performed in the whole population, and in the subgroup of decompensated cirrhotic patients. ''Decompensated cirrhosis'' was defined by the presence of ascites, and/or encephalopathy, and/or variceal bleeding, and/or serum bilirubin Z2.5 mg/dL. 12 For all analyses, quantitative variables were expressed as mean ± standard deviation. A P value r0.05 was considered as statistically significant. Statistical software used was SPSS for Windows, version 11.5.1 (SPSS Inc, Chicago, IL).
RESULTS
Patients
In all, 350 cirrhotic patients were admitted to the Hepato-Gastroenterology Unit of the General Hospital of Le Mans between November 2003 and December 2004. Forty-one patients were excluded from the study because of hepatocellular carcinoma (n = 20), hepatorenal syndrome (n = 4), spontaneous bacterial peritonitis (n = 2), and extrahepatic affection with poor short-term survival (n = 15). Another patient was retrospectively excluded because he killed himself before the sixth month was over. Thus, 308 cirrhotic patients were enrolled in the study. Characteristics of the patients at the time of inclusion are summarized in Table 2 . Cirrhosis was histologically proven in 135 patients (43.8%). Forty-five patients (14.6%) died during the 6-month follow-up. The cause of death was related to liver disease in 38 patients: liver failure (n = 26), renal failure (n = 7), variceal bleeding (n = 4), and hepatocellular carcinoma (n = 1). In the 7 remaining patients, the cause of death was: bleeding gastroduodenal ulcer (n = 2), cerebral hematoma (n = 1), cerebral vascular accident (n = 1), and unknown (n = 3). According to our definition, 154 patients (50.0%) had decompensated cirrhosis at the time of inclusion. Forty-two patients of this group died during the 6-month follow-up, versus only 3 deaths in the group of patients with compensated cirrhosis (27.3% vs. 1.9%, P<10 À 3 ). Causes of death in the group of compensated cirrhosis were liver failure (n = 2) and cerebral hematoma (n = 1). The number of patients lost to follow-up at 3, 5, and 6 months was 0 (0%), 7 (2.3%), and 21 (6.8%), respectively.
Prediction of 6-month Mortality in the Whole Population Accuracy of CP, MELD, and MELD-Na Scores (Tables 3, 4) Six-month cumulative survival was 85.2% in the whole population (Fig. 1) , and respectively for CP Class A, B, and C: 99.3%, 92.2%, and 50.5%. AUROC of CP, MELD, and MELD-Na for the prediction of 6-month mortality were not statistically different (Table 3 ). According to the highest Youden index, the best cut-off for the prediction of 6-month mortality was 10 for the CP score, 16.8 for the MELD, and 18.4 for the MELD-Na (Table 4) . By using these cut-offs, accuracies of the 3 prognostic scores reached no statistical difference (Table 3) . By stepwise binary logistic regression, 6-month mortality was independently predicted by bilirubin at the first step (P = 0.006), urea at the second step (P<10 À 3 ), albumin at the third step (P = 10
), Na at the fourth step (P = 0.019), and ascites at the fifth step (P = 0.036).
Improvement of CP and MELD Scores (Table 5) CP Score
By stepwise binary logistic regression including CP score and all significant univariate variables (except those already included in the CP score), independent predictors of 6-month mortality were: CP score, urea, Na, and alkaline phosphatase. A specific score including these 4 independent variables had a significantly higher AUROC than the CP score: 0.921 versus 0.882 (P = 0.002).
MELD
By stepwise binary logistic regression, independent predictors of 6-month mortality were: MELD, albumin, and Na. A specific score including these 3 independent variables had a significantly higher AUROC than the MELD: 0.906 versus 0.866 (P = 0.004).
Prediction of 6-month Mortality in Decompensated Cirrhotic Patients
Accuracy of CP, MELD, and MELD-Na Scores (Tables 3, 4) Six-month cumulative survival was 72.2% in the group of patients with decompensated cirrhosis (Fig. 2) . AUROC of CP, MELD, and MELD-Na for the prediction of 6-month mortality were not statistically different (Table 3) . According to the highest Youden index, the best cut-off for the prediction of 6-month mortality was 10 for the CP score, 17.9 for the MELD, and 19.0 for the MELD-Na (Table 4) . By using these cut-offs, MELD-Na had the highest accuracy but the difference reached statistical significance only with the CP score ( Table 3) . By stepwise binary logistic regression, 6-month mortality was independently predicted by albumin at the first step (P<10
), bilirubin at the second step (P<10 À 3 ), and creatinine at the third step (P = 0.013). (Table 5) CP Score
Improvement of CP and MELD Scores
By stepwise binary logistic regression including CP score and all significant univariate variables (except those already included in the CP score), independent predictors of 6-month mortality were CP score, urea, Na, and alcoholic cause of cirrhosis. A specific score including these 4 independent variables had a significantly higher AUROC than the CP score: 0.909 versus 0.796 (P<10 À 3 ).
MELD
By stepwise binary logistic regression, independent predictors of 6-month mortality were MELD, alcoholic cause of cirrhosis, albumin, and Na. A specific score including these 4 independent variables had a significantly higher AUROC than the MELD: 0.890 versus 0.800 (P = 0.006).
DISCUSSION
The CP score is a simple prognostic model that has been widely used for over 20 years to predict mortality in patients with cirrhosis. In a recent systematic review of 118 studies, 13 D'Amico et al have shown that the CP score was the most common significant predictor of death (identified in 63% of the studies evaluated), followed by all its components: albumin, bilirubin, ascites, encephalopathy, and prothrombin time. The MELD is a recent prognostic algorithm, harder to use than the CP score and initially elaborated to predict short-tem survival in patients undergoing transjugular intrahepatic portosystemic shunt.
1 Several studies have shown that the MELD was also effective for the prediction of short-term mortality in patients with cirrhosis. 2, 14, 15 In this setting, the MELD has replaced the CP score since February 2002 in the United States for prioritizing liver donor allocation.
Our study shows that the MELD does not have a significantly higher accuracy than the CP score for the MELD indicates model for end-stage liver disease; NPV, negative predictive value (%); OA, overall accuracy (%); PPV, positive predictive value (%); Se, sensitivity (%); Spe, specificity (%). FIGURE 1. Cumulative survival in the whole population. prediction of 6-month mortality. Because a large majority of our patients (>80%) had alcoholic cirrhosis, it should be noticed that our results could not be generalized to all cirrhotic patients, especially those with chronic viral hepatitis or nonalcoholic fatty liver disease. However, they are consistent with the results from many other studies that already reported fairly equivalent MELD and CP score accuracies for the prediction of short-term and intermediate mortality in patients with cirrhosis. 4, 5, 16 Moreover, in a large cohort of 1611 patients with chronic liver disease, 17 MELD and CP score c-statistics for the prediction of 1-year mortality were not significantly different. Thus, although MELD represents determinant progress in terms of methodology and validation, its accuracy for the prediction of outcome in the population of cirrhotic patients is not really superior to the one of CP score, a simple score that can be calculated at bedside.
However, in the subgroup of decompensated cirrhotic patients, our results showed a more marked difference between the CP score and the MELD, and a significant difference between the CP score and the MELD-Na. Indeed, advanced stages of cirrhosis are associated with a marked splanchnic arterial vasodilatation leading to homeostatic activation of vasoconstrictor and antinatriuretic factors. As the disease progresses, there is marked impairment in renal excretion of free water and renal vasoconstriction leading to dilutional hyponatremia and hepatorenal syndrome. 18 Hepatorenal syndrome is associated with a high mortality rate, 19 and recent studies have shown that hyponatremia is a strong predictor of death in cirrhotic patients, 7, 8 both events taken into account by the MELD-Na, which includes creatinine and Na. In this setting, our results show that the adjunction of urea and Na to the CP score significantly improved its accuracy for the prediction of 6-month mortality in the whole population and in the subgroup of decompensated cirrhotic patients, thus demonstrating that the prediction of the cirrhotic patient outcome must take into account not only liver dysfunction, but also circulatory dysfunction and renal failure.
Several studies have suggested that adjunction of Na could improve the MELD accuracy. 7, 8 In this way, Biggins et al have elaborated the MELD-Na, a new score combining Na with the MELD. 9 However, AUROC of the MELD-Na and the MELD in this study were not significantly different because hyponatremia affects only a minority of patients. Our results show that 6-month mortality was independently associated by stepwise binary logistic regression to the MELD at the first step, and to Na only at the third step in the whole population, and the fourth step in the subgroup of patients with decompensated cirrhosis. Moreover, the MELD-Na did not have significantly higher AUROC or accuracy than the MELD no matter which population we consider. Thus, further studies are required to assess what the real gain in accuracy provided by an association of Na to the MELD is. Such studies have to include a large population of patients with end-stage liver disease, and they also have to determine if the better method is to combine MELD itself with Na or to create a new score with a new coefficient for each variable.
Kamath et al 2 showed that the cause of liver disease could be omitted from the MELD with little influence on the c-statistics of the model. In the subgroup of decompensated cirrhosis of our study, including more than 85% alcoholic cause of cirrhosis, alcoholic cause was independently associated with 6-month mortality and was thus a variable that could potentially improve the accuracy of the MELD or the CP score. Indeed, the exclusion of the variable ''liver disease cause'' from the MELD score is perhaps still debatable. In the D'Amico et al review, 13 age was the only variable that is not part of the CP score that was found to be predictive of survival in more than 10 studies. However, age was never independently associated with 6-month mortality in our study. Finally, we did not confirm the potential improvement of the CP score prognostic accuracy by the hyaluronan previously suggested by Korner et al. 10, 20 Instead of adding additional information by other variables, a way to increase the performance of the MELD is to make better use of its components. The INR is a standardization of the prothrombin time during oral anticoagulation. However, mechanisms of the prothrombin time prolongation in liver diseases differ from those involved in oral anticoagulation. 21, 22 Thus, in patients with liver failure, the INR fails to yield a prothrombin time expression independent of the thromboplastin used. 23 In this way, recent studies have shown that a thromboplastin calibration using plasmas from patients with cirrhosis instead of from vitamin K antagonist patients allows the calculation of a specific International Sensitivity Index that eliminates variability in the INR results. 24, 25 As a consequence, discrepancy between the MELD calculated with the ''standard'' INR or the ''specific'' INR for liver disease Multivariate analysis included the Child-Pugh (CP) score or the MELD and all variables with a univariate P r0.05, except those already included in the studied score.
MELD indicates model for end-stage liver disease.
was up to 4 points in more than half of the cases. 24 Thus, standardization of the INR in liver disease should be another way to improve the MELD accuracy.
In conclusion, the MELD and the CP scores are equivalent tools for the prediction of 6-month mortality in cirrhotic patients. However, when taking into account only patients with decompensated cirrhosis, the MELD and especially the MELD-Na seems to be more accurate than the CP score. The prognostic accuracy of the MELD and the CP score could be ameliorated by adding variables reflecting the circulatory dysfunction observed in end-stage liver disease.
